Registered entities
ANTABIO
Reg. No. 517511291France
Innovation
19 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 748 times.
| Year | Filings |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 9 |
| 2021 | 6 |
| 2022 | 6 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 3 |
Social engagement
Social engagement: 7.5K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
13 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 15% |
| Private equity | 6 | 46% |
| Accelerator & incubator | 1 | 8% |
| Other / undisclosed | 4 | 31% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
17 Jun 2026 · Administrative Assistant
Based on job postings tracked across public sources.
Recent activity
26 May 2026
Event
BIO International Convention 2026
21 May 2026
Event
5th SCI / RSC Symposium on Anti-Infectives Drug Discovery
27 Apr 2026
Product launch
meropenem–pilabactam (formerly Meropenem-ANT3310)